Leigh syndrome is a rare genetic condition that affects the brain and nervous system. It usually starts in infancy or early childhood and tends to be progressive. Common signs include trouble feeding, poor weight gain, weak muscle tone, movement problems, and breathing issues, and doctors may also see changes on brain MRI. Treatment focuses on supportive care, nutrition, seizure control, and sometimes vitamin or cofactor therapies, but there is no cure. The outlook varies, but many people with Leigh syndrome have serious health needs, and early, coordinated care can help manage complications.
Overview
Leigh syndromeSymptoms
Leigh syndrome often begins in infancy with feeding trouble, poor weight gain, low muscle tone, and developmental delay or loss of skills. Early symptoms of Leigh syndrome include vomiting, breathing problems, weakness, and seizures. Some develop vision or movement difficulties.
Outlook and prognosis
Leigh syndrome often begins in infancy or early childhood and can progress quickly, affecting movement, breathing, and feeding. Outlook varies by genetic cause and organ involvement; early symptoms of Leigh syndrome sometimes stabilize with targeted support. Close monitoring and mitochondrial-focused care help maximize quality of life.
Causes and risk factors
Leigh syndrome stems from pathogenic variants in mitochondrial or nuclear genes, inherited maternally, autosomal recessively, or rarely X‑linked. Risk rises with family history or parental relatedness. Illness, fasting, and metabolic stress can worsen severity, but are not causes.
Genetic influences
Genetics is central in Leigh syndrome. Most people have inherited variants in mitochondrial or nuclear genes that disrupt energy production; patterns include maternal, autosomal recessive, or rarely X‑linked inheritance. Specific gene changes strongly influence age of onset, symptoms, and severity.
Diagnosis
Doctors combine clinical features with brain MRI and blood or spinal fluid tests to look for typical patterns and raised lactate. Genetic diagnosis of Leigh syndrome uses DNA testing of mitochondrial and nuclear genes to confirm the cause.
Treatment and drugs
Treatment for Leigh syndrome focuses on supportive care, targeted nutrition, and managing energy needs. Care teams may use vitamins or cofactors like thiamine, riboflavin, coenzyme Q10, or L‑carnitine, plus tailored feeding, seizure control, breathing support, and physical, speech, and occupational therapy. Some benefit from avoiding prolonged fasting, infections, and certain medicines that strain mitochondria; clinical trials are exploring new options.
Symptoms
Many families first notice slowed or lost milestones, floppy muscle tone, or feeding struggles that don’t match a child’s age. The changes are often subtle at first, blending into daily life until they become more noticeable. Early features of Leigh syndrome can include weak head control, poor weight gain, unsteady movements, and fast or irregular breathing during colds. Features can vary widely and may appear in infancy, childhood, or later, with some people also developing vision, hearing, seizure, or movement issues over time.
Skills like sitting, crawling, or talking may come later than expected. Some children lose skills they had before, especially after an illness. This pattern can happen in Leigh syndrome.
Muscles may feel floppy, and holding up the head can be hard. Clinicians call this hypotonia, which means low muscle tone.
Babies may have a weak suck or tire while feeding. Older children may take longer to eat or cough and choke with liquids. This can lead to poor weight gain.
Breathing may be unusually fast, shallow, or irregular, especially during colds or fever. In Leigh syndrome, these breathing changes can flare during infections. They can disrupt sleep and daily activity.
How people usually first notice Leigh syndrome?
Many families first notice Leigh syndrome in infancy when a baby who seemed to be developing normally starts losing skills like head control, rolling, or feeding well, sometimes after a common illness. Doctors may be alerted by low muscle tone, poor weight gain, unusual eye movements, vomiting, or rapid breathing, and brain MRI or metabolic blood tests then point to the diagnosis. In older infants or toddlers, the first signs of Leigh syndrome can be trouble walking, frequent falls, or developmental regression, which prompts evaluation for a mitochondrial condition.
Types of Leigh syndrome
Leigh syndrome has several recognized clinical variants. They share core features like developmental regression and movement or breathing issues, but the timing, severity, and organs affected can differ. Researchers describe these categories to better understand patterns of the condition. When people look up types of Leigh syndrome, they’re usually referring to variants based on the gene or enzyme system involved rather than separate diseases.
Mitochondrial DNA variant
Changes in the mitochondrial genome often start symptoms in infancy or early childhood. These can bring rapid neurologic decline, feeding trouble, and muscle weakness. Hearing or vision loss may appear over time.
Complex I deficiency
This nuclear-gene form affects the first step of the respiratory chain, often causing early, severe symptoms. Babies may develop poor tone, vomiting, and breathing problems during infections. Some children have slower progression with supportive care.
Complex IV (SURF1)
Variants in SURF1 disrupt complex IV and commonly lead to classic Leigh features in infancy. Many have frequent breathing instability and failure to thrive. Vision changes can develop as the condition progresses.
Complex V (ATP synthase)
Faults in ATP synthase reduce cellular energy and can trigger feeding issues, weakness, and developmental slowing. Lactate levels are often elevated in blood or spinal fluid. Severity ranges from early life onset to later childhood.
PDH deficiency variant
Problems in the pyruvate dehydrogenase complex can produce a Leigh-like picture with high lactate. Episodes may worsen with illness or fasting. Some benefit from specific dietary strategies advised by specialists.
CoQ10 biosynthesis defect
Genes that disrupt coenzyme Q10 production can cause Leigh syndrome features with variable severity. Some people improve with CoQ10 supplementation if started early. Not everyone responds the same way.
Leigh-like presentations
A few genetic changes lead to syndromes that closely resemble Leigh syndrome. People may show similar brain MRI patterns and symptoms but have slightly different progression. Diagnosis relies on genetic testing to sort between variants of Leigh syndrome and Leigh-like disorders.
What genetics can tell you about symptoms
Some people with Leigh syndrome who have MT-ATP6 changes tend to develop early feeding problems, weak muscle tone, and rapid breathing because the cell’s “power stations” make less energy. Variants in SURF1 often link to slower growth, eye-movement troubles, and characteristic brainstem MRI changes.
Causes and risk factors
Leigh syndrome is driven by gene changes that impair how mitochondria make energy. Some risks are written in our DNA, passed down through families. These changes may lie in mitochondrial DNA from the mother, in nuclear genes from both parents, or rarely on the X chromosome. Risk is higher with a family history or when parents are related or share close ancestry, yet a new change can also arise with no family history. Infections, fever, fasting, and some medicines can strain energy pathways, so early symptoms of Leigh syndrome may appear or worsen during illness.
Environmental and biological risk factors
Leigh syndrome often appears early in life, and many families ask whether anything in the surroundings raised the chance. So far, there are very few environmental or body-based factors proven to increase the likelihood of it occurring. Researchers are still exploring how outside influences interact with our inner biology. Questions about early symptoms of Leigh syndrome are common, but here we’re focusing on what is known about environmental and biological risk.
Studies have not shown a consistent link between either parent’s age and the chance of Leigh syndrome. Age-related effects seen in other conditions have not been confirmed here.
Common viral or bacterial infections during pregnancy have not been shown to increase the likelihood of the condition. Treatment during pregnancy still matters for overall fetal health.
Typical medical or workplace radiation levels have no established association with Leigh syndrome occurring. As always, unnecessary exposure should be minimized during pregnancy.
Parental exposure to lead, mercury, or similar toxins has not been linked to a higher chance of the condition. Reducing toxic exposures remains good practice for general health.
Genetic risk factors
Leigh syndrome often stems from inherited or new changes in genes that run mitochondria, the cell’s energy system. Most cases come from variants in nuclear genes passed in an autosomal recessive pattern; others arise from mitochondrial DNA carried through the maternal line, and a smaller share from X-linked genes. Carrying a genetic change doesn’t guarantee the condition will appear. Which genes are involved and how the change is inherited can shape age at onset, severity, and who else in the family may be at risk.
Autosomal recessive variants: Many cases of Leigh syndrome occur when a child inherits one nonworking copy of the same gene from each parent. Parents are usually healthy carriers, but each pregnancy has a 25% (1 in 4) chance of an affected child.
Maternal mtDNA variants: Changes in mitochondrial DNA are passed down from the mother to all her children. Only mothers pass them on, and the amount of altered mtDNA can influence how severe Leigh syndrome becomes.
X-linked changes: Variants on the X chromosome, often involving the pyruvate dehydrogenase gene, can cause this condition. Males are typically more affected, while females can be variably affected due to X-chromosome inactivation.
Heteroplasmy level: The proportion of altered mitochondrial DNA versus normal copies can act like a dimmer switch on disease severity. Higher loads can bring earlier onset and shape the early symptoms of Leigh syndrome. Lower levels may cause milder or later problems.
New (de novo) variants: Sometimes a genetic change arises for the first time in a child, with no prior family history. Recurrence risk for siblings is usually low, but can be higher if a parent has germline mosaicism.
Energy chain genes: Changes in genes that build or run the cell’s energy chain (Complex I, IV, or V) are a frequent genetic cause. These include nuclear genes that assemble these complexes and mitochondrial DNA genes that code key subunits.
SURF1 and Complex IV: Variants in the SURF1 gene are a well-known nuclear cause linked to low activity of Complex IV. This pattern is often associated with classic features seen in Leigh syndrome.
Family history clues: Multiple affected siblings suggest an autosomal recessive cause, while affected individuals across a maternal line suggest mitochondrial DNA inheritance. A mix of affected males with milder or no symptoms in females can hint at an X-linked pattern.
Population clusters: Certain genetic variants can be more common in specific regions or communities due to founder effects. Knowing ancestral background can sometimes guide which genes to test first.
Lifestyle risk factors
Leigh syndrome is a genetic mitochondrial condition; lifestyle habits do not cause it, but they can influence symptoms, day‑to‑day functioning, and the risk of metabolic decompensation. Understanding how lifestyle affects Leigh syndrome helps families make choices that reduce stress on the mitochondria. Below are practical lifestyle risk factors for Leigh syndrome tailored to its energy-production challenges.
Gentle, regular movement can help maintain muscle strength and mobility. Overexertion can trigger severe fatigue or lactic acidosis in Leigh syndrome.
Long gaps without food push the body into a catabolic state that strains impaired mitochondria. Regular meals and snacks can stabilize energy and reduce metabolic crises.
Adequate calories and protein support growth and tissue repair when energy production is limited. Work with a metabolic dietitian to individualize macronutrients, as needs vary in Leigh syndrome.
Overheating or extreme cold can increase metabolic demand and worsen weakness or breathing difficulty. Dressing in layers and avoiding hot environments may reduce symptom flares.
Risk prevention
Leigh syndrome affects energy supply in many organs, so prevention focuses on lowering the chance of metabolic crises and catching problems early. Prevention is about lowering risk, not eliminating it completely. For family planning, genetic counseling and specific reproductive options can reduce the chance of Leigh syndrome in future pregnancies. Knowing the early symptoms of Leigh syndrome and acting quickly during illnesses can also limit complications.
A genetics team can explain inheritance patterns and personal risks. They can outline options for future pregnancies and testing for relatives.
Biological parents and at-risk relatives can consider targeted genetic tests. Results guide family planning and help identify who might benefit from extra monitoring.
In-vitro fertilization with preimplantation genetic testing can select embryos without the known familial change. This may lower the chance of Leigh syndrome in future children.
In countries where it’s available, mitochondrial replacement techniques may reduce transmission for certain mitochondrial DNA causes. A specialist clinic can discuss eligibility and limits.
Transmission
Leigh syndrome is not contagious; it is a genetic condition passed through families or caused by a new change in a gene. In most families, how Leigh syndrome is inherited follows an autosomal recessive pattern—both parents carry one nonworking copy of a gene, and a child is affected only if they inherit both nonworking copies. In some cases, the genetic transmission of Leigh syndrome involves mitochondrial DNA that is passed down only from the mother; her children can inherit the change, but symptoms can vary even within a family. Rarely, an X-linked change can cause Leigh syndrome, which can affect boys more severely. Sometimes the gene change happens for the first time in a child, so there may be no family history.
When to test your genes
Consider genetic testing if you or a close relative had early-onset, unexplained neurologic symptoms—such as regression, seizures, movement or balance problems, or persistent lactic acidosis—especially in infancy or childhood. Testing also makes sense before family planning or if MRI suggests Leigh syndrome. A confirmed diagnosis can guide treatment, surveillance, and mitochondrial-appropriate anesthesia.
Diagnosis
Diagnosis of Leigh syndrome focuses on patterns doctors can see and measure, then confirms the cause with specific tests. Many people feel relief just knowing what’s really going on. When this condition is suspected, the genetic diagnosis of Leigh syndrome is usually reached by combining imaging, metabolic studies, and genetic testing.
Doctors usually begin with a detailed review of symptoms and development. They look for early neurologic changes, feeding issues, breathing troubles, and episodes triggered by infections.
The exam checks muscle tone, reflexes, eye movements, and coordination. Findings such as weakness, dystonia, or abnormal eye movements can support Leigh syndrome.
Imaging often shows symmetric changes in the basal ganglia or brainstem. These MRI patterns, especially during or after illness, are classic for Leigh syndrome.
Blood and sometimes spinal fluid are tested for lactate, pyruvate, and acid–base balance. Elevated lactate or a high lactate-to-pyruvate ratio can point toward mitochondrial disease.
Stages of Leigh syndrome
Leigh syndrome does not have defined progression stages. The course can vary widely based on the age symptoms start, which body systems are involved, and the specific genetic change; some children worsen quickly, while others change more slowly with occasional setbacks during illnesses. Different tests may be suggested to help confirm what’s going on, such as brain scans (MRI), blood or urine checks, and genetic testing. Doctors often track early symptoms of Leigh syndrome along with growth, movement, and breathing, and may repeat imaging or lab tests over time to monitor changes.
Outlook and prognosis
Daily routines often adapt as families learn to pace activities, support nutrition, and watch for early symptoms of Leigh syndrome such as feeding trouble, slower motor skills, or episodes of unusual breathing. Prognosis refers to how a condition tends to change or stabilize over time. Leigh syndrome is typically progressive, especially in infancy and early childhood, and flare‑ups can follow common triggers like infections. Some people experience rapid changes over weeks to months, while others notice a slower course with periods of seeming stability between setbacks.
The outlook is not the same for everyone, but it’s shaped by the specific genetic cause, how much the mitochondria are affected, and how early supportive care starts. For infants with severe forms, mortality can be high in the first years of life, often related to breathing control, heart strain, or overwhelming infection; children with milder variants may live longer into later childhood or beyond. With ongoing care, many people maintain comfort and meaningful interaction even as mobility or swallowing change. Looking at the long-term picture can be helpful, because proactive steps—respiratory support, nutrition plans, seizure control, and infection prevention—can reduce complications.
Genetic testing can sometimes provide more insight into prognosis. Not everyone with the same gene change will have the same outlook, but knowing the underlying mutation can guide monitoring and treatment choices, and in some cases points to vitamin or cofactor therapies that may help. Talk with your doctor about what your personal outlook might look like. Early care can make a real difference, and regular follow‑up with neurology, genetics, respiratory, and nutrition teams can help you plan ahead while focusing on quality of life now.
Long-term effects
Leigh syndrome is a progressive mitochondrial brain and muscle condition that can lead to ongoing neurologic and organ changes over time. Long-term effects vary widely, and they can shift with growth, illness, or stress. While early symptoms of Leigh syndrome often begin in infancy, some people reach later childhood or adulthood, and the pace can speed up during infections. Care teams focus on supportive care and watching for complications that can affect daily function and safety.
Skills children once had can fade over months or years. This may include sitting, walking, or talking.
Stiff or twisting movements and shaky balance can make walking hard. Falls, ataxia, or dystonia may become more frequent over time.
Low muscle tone and tiring easily can limit play, school, or work. Lifting the head, climbing stairs, or fine hand tasks may get harder.
Swallowing can become unsafe or slow, increasing the risk of choking. Poor intake can lead to weight loss and slow growth.
How is it to live with Leigh syndrome?
Living with Leigh syndrome often means navigating fatigue, weak muscle tone, and episodes of regression after common stressors like infections, which can make everyday tasks—walking, feeding, speaking, or learning—more effortful and unpredictable. Many families build routines around energy conservation, specialized nutrition, seizure management, and frequent appointments with neurology, cardiology, ophthalmology, and physical, occupational, and speech therapy. For those around the person, the impact can be profound—caregivers balance vigilance with preserving a child’s joy, siblings adapt to changing plans, and communities learn to support accessibility and infection precautions. Even with these challenges, coordinated care, adaptive equipment, and clear emergency plans can ease daily life and help families focus on shared moments of comfort and connection.
Treatment and drugs
Treatment for Leigh syndrome focuses on easing symptoms, supporting energy production in cells, and preventing complications, since there’s no single cure yet. Doctors may use vitamin and cofactor supplements such as thiamine (vitamin B1), riboflavin (vitamin B2), coenzyme Q10, and L‑carnitine to help mitochondria work better, though benefits vary from person to person. Seizures, movement problems, muscle stiffness, and feeding issues are treated with standard therapies—antiepileptic medicines, muscle relaxants, nutrition support (including feeding tubes if needed), and physical, occupational, and speech therapy. Treatment often looks different for each person, and care is usually coordinated by a neurologist and a metabolic or mitochondrial specialist, with regular monitoring of the heart, vision, breathing, and growth. Clinical trials are exploring new options, including gene‑targeted therapies for certain genetic forms, so ask your doctor if research studies might be suitable for you.
Non-drug treatment
Living with Leigh syndrome often means managing movement, feeding, breathing, and fatigue in daily life. Alongside medicines, non-drug therapies can support comfort, function, and quality of life. Understanding early symptoms of Leigh syndrome can help teams start the right supports sooner. Care plans are tailored and may change as needs change.
A dietitian can adjust calories, fluids, and meal timing to maintain growth and steady energy. Avoiding long fasts and staying well hydrated may reduce crashes.
Vitamins and nutrients like thiamine, riboflavin, or coenzyme Q10 are sometimes used to support cell energy. Benefits vary by individual and need regular monitoring.
A high-fat, very low-carb plan may help seizures and energy in selected cases. It must be medically supervised with routine blood and growth checks.
Gentle strength, balance, and stretching help maintain mobility and prevent tight joints. Sessions are paced to avoid overexertion and post-exercise fatigue.
Your genes may have an impact on how drugs work for you
Medicines for Leigh syndrome can work differently depending on genetic cause, because specific mutations change how cells make and use energy. That’s why care teams often tailor supplements, mitochondrial cofactors, and dosing based on the person’s exact variant and response.
Pharmacological treatments
Medicines for Leigh syndrome aim to ease symptoms, correct nutrient or enzyme shortfalls, and manage complications; they are not a cure. Choices are tailored to the genetic cause when known and to the problems affecting daily life, and they’re often paired with nutrition, physical therapy, and breathing support. While treatment won’t undo nerve injury or the early symptoms of Leigh syndrome, starting the right supports early may steady energy and reduce crises. Not everyone responds to the same medication in the same way.
High-dose thiamine may help when Leigh syndrome is linked to pyruvate dehydrogenase complex problems. It can lower lactic acid levels and improve energy in some people. Doctors may try it because safety is generally good.
Riboflavin can support mitochondrial enzyme complexes and is helpful in certain riboflavin-responsive genetic forms. People may notice better stamina or less weakness over time. Benefits depend on the underlying mutation.
CoQ10 (or ubiquinol) may help when there is a primary CoQ10 deficiency or low levels are suspected. It can reduce fatigue and support muscle strength. Some continue it long term if they feel sustained benefit.
Carnitine helps the body use fat for energy and may be low in chronic illness. Supplementing can improve tiredness and reduce muscle aches when levels are low. Blood levels are usually checked and dosing adjusted as needed.
Genetic influences
Leigh syndrome most often stems from changes in genes involved in the parts of cells that make energy (mitochondria). Family history is one of the strongest clues to a genetic influence. In many families, it’s inherited when both parents carry a silent gene change, giving each pregnancy a 1 in 4 (25%) chance of a child with Leigh syndrome. In other families, a change sits in mitochondrial DNA and is passed down by the mother; it can affect each child to a different degree, influencing age of onset and early symptoms, and only daughters can pass it forward. Less often, a gene on the X chromosome is involved, so boys are more commonly affected. Sometimes the gene change is new in the child, with no prior family history. Genetic testing that looks at mitochondrial DNA and the rest of your genes can confirm the cause and help plan care and future pregnancies.
Is Leigh syndrome genetic?
Genetics is central in Leigh syndrome. Most people have inherited variants in mitochondrial or nuclear genes that disrupt energy production; patterns include maternal, autosomal recessive, or rarely X‑linked inheritance. Specific gene changes strongly influence age of onset, symptoms, and severity.
Pharmacogenetics—how genetics influence drug effects
The exact gene change causing Leigh syndrome can shape which treatments help and which medicines to avoid. Alongside medical history and current symptoms, genetic testing can help doctors tailor supplements, diets, and seizure medicines, and flag drugs that need extra caution. Some genetic forms respond better to certain vitamins or cofactors—like high-dose thiamine in thiamine-related types, riboflavin for a few energy-chain defects, or coenzyme Q10 when the body struggles to make it. Genetics also guides medications to avoid with Leigh syndrome: valproate is unsafe in POLG-related disease because it can cause severe liver injury, and specific mitochondrial DNA changes can make aminoglycoside antibiotics especially risky for hearing. Teams plan procedures and everyday care with this in mind, using caution with anesthesia, metformin, and linezolid, which can raise lactic acid or stress mitochondria; alternatives or closer monitoring are often used instead. Because responses differ from person to person, treatment is adjusted over time, and it’s worth asking whether your or your child’s exact genetic result should change current medication choices for Leigh syndrome, including medications to avoid with Leigh syndrome.
Interactions with other conditions
In Leigh syndrome, other illnesses can quickly tip the balance—common colds, flu, or stomach bugs often drain energy, raise lactic acid levels, and can trigger setbacks in skills or breathing. A condition may “exacerbate” (make worse) symptoms of another, so infections, untreated sleep apnea, or asthma often make fatigue, weakness, and feeding problems from Leigh syndrome more noticeable. Seizure disorders frequently occur alongside Leigh syndrome and may flare during fevers, while heart muscle problems or rhythm issues can compound shortness of breath and poor exercise tolerance. Some develop diabetes or difficulty controlling blood sugar, which can worsen energy crashes and dehydration; kidney or liver issues can also influence how the body handles medications and waste products. Especially when early symptoms of Leigh syndrome are emerging, even routine illnesses may have a bigger impact than expected, so vaccinations and prompt care for fevers or breathing trouble are important. Talk with your doctor about how your conditions may influence each other, including anesthesia plans, antibiotic choices, and nutrition support, so care teams can act early and lower the risk of severe complications.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies and young children who lost milestones after an illness, grew weak, and had trouble breathing or feeding. Families told stories of a child who once sat or crawled but then seemed to fade, while doctors noted unusual eye movements, stiff or floppy muscles, and sudden episodes of rapid breathing. Looking back helps explain how Leigh syndrome came to be recognized as a specific condition rather than a collection of puzzling symptoms.
First described in the medical literature as a “subacute necrotizing encephalomyelopathy” in the 1950s, the pattern stood out: early development that seemed typical, followed by regression and problems with the brainstem and deep brain structures that control movement and vital functions. In the decades that followed, careful clinical reports linked similar cases across hospitals and countries. Early imaging with CT, and later MRI, showed characteristic changes deep in the brain that matched what doctors saw at the bedside—trouble with balance, swallowing, eye control, and breathing.
From early theories to modern research, the story of Leigh syndrome reflects the rise of mitochondrial medicine. In the 1980s and 1990s, laboratory advances showed that many people with Leigh syndrome had problems in the cell’s energy-making machinery. That explained why tissues with the highest energy needs—brain, nerves, muscles, and the heart—were most affected. Some families showed inheritance through the mother, pointing to mitochondrial DNA changes, while others followed autosomal or X-linked patterns due to gene changes in the cell nucleus. This clarified why two children in the same family might have different ages of onset or symptom severity.
With each decade, testing improved. Enzyme studies of the respiratory chain, targeted gene tests, and then next-generation sequencing allowed doctors to move from describing symptoms to naming the exact gene involved. This shift helped identify milder and later-onset forms, so Leigh syndrome was no longer seen only as a condition of infancy. It also explained why early symptoms of Leigh syndrome can vary—from feeding issues and poor growth to movement problems, low muscle tone, or episodes triggered by common infections.
In recent decades, awareness has grown as newborn screening, metabolic evaluations, and genetic panels became more available. International registries and collaboration have refined care guidelines and highlighted that timely supportive care—nutrition, respiratory support, seizure management—can influence outcomes. Not every early description was complete, yet together they built the foundation of today’s knowledge. The history of Leigh syndrome is still being written as researchers study how different gene changes affect energy production and explore targeted therapies, offering a clearer path from recognition to personalized care.